SCHEMBL30031744

SCHEMBL30031744

COc1ccn2c3c(nc2c1OC(F)F)-c1[nH]c(=O)c(C(=O)O)cc1C(C(C)(C)C)C3

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031210 1.00 CNR2 (0.32) CNR2
SCHEMBL30031826 1.00 CNR2 (0.32) CNR2
SCHEMBL24357393 0.92 CNR2 (0.35) CNR2
SCHEMBL24357108 0.86 HCRTR2 (0.30) —
SCHEMBL30031308 0.85 IDH1 (0.31) —
SCHEMBL30030840 0.85 IDH1 (0.31) —
SCHEMBL30031474 0.85 IDH1 (0.31) —
SCHEMBL24357019 0.84 KDM4E (0.32) CNR2
SCHEMBL30031695 0.83 KDM4E (0.32) —
SCHEMBL30031721 0.83 KDM4E (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022214937-A1 SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2022-10-13 — — WO disclosed
Send feedback